Primary Site >> Biliary tract Cancer

Gene >> LCN2

Journal: Int J Hepatol. 2011;2011:873548.
Title: Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases.
Author: Leelawat, Kawin|Narong, Siriluck|Wannaprasert, Jerasak|Leelawat, Surang
PMID: 21994874
Journal: Oncotarget. 2014 Jun 15;5(11):3849-61.
Title: Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model.
Author: Chiang, Kun-Chun|Yeh, Chun-Nan|Lin, Kun-Ju|Su, Li-Jen|Yen, Tzu-Chen|Pang, Jong-Hwei S|Kittaka, Atsushi|Sun, Chi-Chin|Chen, Miin-Fu|Jan, Yi-Yin|Chen, Tai C|Juang, Horng-Heng|Yeh, Ta-Sen
PMID: 24939880
Journal: Int J Oncol. 2017 Jul;51(1):269-280.
Title: Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Author: Verathamjamras, Chris|Weeraphan, Churat|Chokchaichamnankit, Daranee|Watcharatanyatip, Kamolwan|Subhasitanont, Pantipa|Diskul-Na-Ayudthaya, Penchatr|Mingkwan, Kanokwan|Luevisadpaibul, Virat|Chutipongtanate, Somchai|Champattanachai, Voraratt|Svasti, Jisnuso
PMID: 28560424